Daliresp (Roflumilast) — Patient Guide (Australia)

Daliresp is a prescription medicine used in the treatment of certain chronic lung conditions. This guide explains how roflumilast works, how it’s typically used, what to expect, and important safety information for patients in Australia. Always follow the advice of your healthcare professional and the directions on the product label.

1. Basic Product Information

Note: Availability, tablet strengths, and exact prescribing details can vary. Your pharmacist can confirm the correct product strength and instructions for your prescription.

2. What Daliresp Is Used For (Indications)

In Australia, Daliresp (roflumilast) is used as an add-on maintenance treatment for adults with moderate to severe COPD who are at risk of exacerbations. It is specifically indicated for helping to reduce flare-ups (exacerbations) in selected patients.

• Primary condition: Chronic obstructive pulmonary disease (COPD)
• Goal: Reduce exacerbations and help manage chronic symptoms
• Not a rescue inhaler: It is not intended to stop sudden breathing attacks

3. How It Works (Mechanism of Action)

Roflumilast belongs to a class called phosphodiesterase-4 (PDE4) inhibitors. PDE4 is an enzyme involved in controlling inflammatory signalling in the lungs.

Mechanism in simple terms: By inhibiting PDE4, roflumilast helps reduce the release of inflammatory mediators (such as cytokines), which may contribute to ongoing airway inflammation in COPD. This can help lower the likelihood of COPD exacerbations over time.

• Anti-inflammatory effect: Targets cellular pathways linked to chronic inflammation
• Exacerbation prevention (selected patients): Helps reduce flare-ups rather than providing immediate bronchodilation

4. When to Take Daliresp (Timing & Routine)

Daliresp is typically taken once daily. Many patients find it easiest to take at the same time each day. Because side effects (especially gastrointestinal symptoms) can occur, a consistent routine may help.

• Choose a time you can stick to: Morning or evening—ask your prescriber/pharmacist for personalised advice.
• Take with or without food: See food interactions below.
• Do not double up: If you miss a dose, take it when you remember unless it’s close to your next dose. Do not take extra to “catch up”.

If you’re experiencing nausea or diarrhoea, your pharmacist may suggest practical strategies (e.g., timing adjustments) that suit your situation.

5. Food Interactions & Taking With Meals

Roflumilast can generally be taken with or without food. However, individual tolerance varies—some people feel better taking it with a meal, while others prefer it on an emptier stomach.

• Food: Taking with food may reduce stomach discomfort for some patients.
• Grapefruit / specific foods: There are no well-known “grapefruit warnings” for roflumilast in routine guidance, but always discuss your diet and supplements if you take many medicines.

If you notice symptoms worsen after taking Daliresp, consult your healthcare professional before changing your dose schedule.

6. Alcohol & Medicine Interactions

Alcohol

There is no universal rule that prohibits alcohol with roflumilast; however, alcohol can worsen side effects in some people, particularly:

• Nausea
• Dizziness
• Sleep disturbance
• Diarrhoea or stomach upset

If you choose to drink, consider keeping intake low and avoiding alcohol around the time you’re most likely to experience side effects. If you notice increased adverse effects, avoid alcohol and seek advice.

Important medicine interactions

Roflumilast can interact with medicines that affect liver enzymes (particularly pathways involving CYP enzymes) or medicines that can add to side effects. It’s important to tell your pharmacist about all medicines you use, including over-the-counter products and supplements.

Key interaction considerations include:

• Enzyme inducers (may reduce roflumilast levels): Some medicines can lower the effect of roflumilast by increasing its breakdown.
• Certain antibiotics/antifungals and antifungals can potentially affect roflumilast metabolism (raising levels).
• Other treatments for COPD: Daliresp is often used alongside inhalers and other COPD medicines; most combinations are feasible, but medication review is essential.

To keep you safe, ask your pharmacist to check interactions with: inhalers, oral steroids, antibiotics, antifungals, antidepressants, seizure medicines, and any long-term medications.

7. Pharmacokinetics (How the Body Processes Roflumilast)

Pharmacokinetics (PK) describes how a medicine is absorbed, distributed, metabolised, and eliminated. While individual PK can vary, the following explains typical behaviour of roflumilast.

• Absorption: After oral administration, roflumilast is absorbed through the gastrointestinal tract.
• Peak levels: Blood concentrations increase after dosing, reaching peak levels after a number of hours (timing can vary by patient).
• Metabolism: Roflumilast is metabolised primarily in the liver.
• Active metabolites: The medicine and its metabolites contribute to overall effect.
• Elimination: The drug and metabolites are eliminated through the body’s normal clearance pathways, including renal and non-renal routes depending on metabolite characteristics.
• Steady state: With once-daily dosing, blood levels may build gradually until steady state is achieved.

Because roflumilast is processed in the liver, clinicians may adjust decisions based on liver function and medication history. If you have liver disease, your prescriber should weigh benefits and risks carefully.

8. Typical Dosing (General Guidance)

Dosing depends on the specific patient factors, tolerance, and the treatment plan for COPD. Your pharmacist can confirm the exact strength and schedule.

Common approach:

• Once daily administration (dose may start at a lower strength then adjust depending on tolerability, per clinical guidance).
• Take consistently at the same time each day.

Do not change your dose without medical advice. If you experience troubling side effects, contact your healthcare professional promptly—dose timing or management strategies may be possible.

9. Safety Profile & Side Effects

Like all medicines, Daliresp can cause side effects. Many are mild and improve as your body adjusts, but some require prompt medical attention.

Common side effects

• Diarrhoea
• Nausea
• Weight loss
• Decreased appetite
• Headache
• Abdominal discomfort
• Dizziness (in some patients)

Serious warnings (seek medical advice promptly)

• Unintentional weight loss or appetite loss that becomes significant. Your clinician may monitor weight regularly and reassess treatment if weight decreases too much.
• Severe diarrhoea, dehydration symptoms, or persistent vomiting.
• Mood or behaviour changes such as new or worsening depression, anxiety, or suicidal thoughts. Mental health changes should be treated urgently—contact your doctor immediately or seek emergency help.
• Allergic reactions (e.g., swelling of the face/lips, rash with breathing difficulty).

Who needs extra caution?

• History of depression or mood disorders
• Low body weight or a history of unintended weight loss
• Liver problems
• People prone to gastrointestinal side effects (e.g., frequent diarrhoea)

10. Practical Use Tips (How to Maximise Benefits & Minimise Discomfort)

• Start and adjust carefully: If you’re new to Daliresp, give your body time to adapt, but don’t ignore persistent or severe symptoms.
• Monitor your weight: Consider tracking your weight weekly. Report rapid or unintended weight loss to your healthcare professional.
• Manage GI side effects:
  • Taking the dose with food may help nausea or stomach discomfort.
  • Hydrate well, especially if you develop diarrhoea.
  • Avoid large, greasy meals around dosing if they worsen symptoms.
• Keep an eye on mood: Let your doctor know early if you notice changes in mood, sleep, or motivation.
• Use COPD medicines as directed: Daliresp supports long-term management; you’ll still likely need maintenance inhalers and possibly rescue medication.
• Adherence matters: Exacerbation reduction is a longer-term goal; take your medicine regularly as instructed.

11. What to Expect: Effect Timing

COPD flare-up prevention typically requires consistent use over time. Many patients do not notice immediate improvements in breathing the same way they may with bronchodilator “rescue” treatments.

• Initial adjustment period: Side effects may appear early; monitoring helps.
• Longer-term benefit: Reduction in exacerbations is generally assessed over weeks to months.
• Follow-up is important: Your clinician may review symptoms, exacerbation history, lung function, and weight.

12. Alternative Options (Discuss With Your Healthcare Professional)

There are several treatment strategies for COPD, and “best choice” depends on your symptom pattern, exacerbation history, comorbidities, and tolerability. If Daliresp isn’t suitable, alternatives may include:

• Inhaled maintenance therapies (e.g., long-acting bronchodilators, inhaled corticosteroid combinations where appropriate)
• Smoking cessation support (the most important intervention for many patients)
• Pulmonary rehabilitation for symptom improvement and exercise capacity
• Vaccinations to reduce respiratory infections that can trigger exacerbations
• Other anti-inflammatory approaches or different add-on therapies, depending on clinical factors

Your pharmacist or doctor can also discuss how your current inhalers and medications may be optimised to reduce exacerbations.

13. Market & Legal Context in Australia (How It’s Made Available)

In Australia, medicines like Daliresp (roflumilast) are regulated under the Australian prescription medicines framework. Patients typically obtain Daliresp through lawful supply channels consistent with Australian medicines legislation.

• Regulation: Prescription medicines are subject to approval and dispensing requirements.
• Supply: Online pharmacies in Australia must operate within applicable laws and verification processes.
• Quality: Trusted suppliers should provide medicines that meet Australian regulatory standards.

For the safest use, confirm that you’re receiving the correct product strength and that packaging is intact when delivered.

14. Recent Guidance (What to Watch for)

Clinical recommendations for COPD management can evolve over time as new evidence becomes available. In recent years, guidance has consistently emphasised:

• Individualised COPD management based on exacerbation risk and symptoms
• Optimising inhaled therapy and adherence to maintenance treatments
• Assessing risk of medication side effects, including weight loss and mood-related effects where relevant
• Regular review of treatment effectiveness (e.g., exacerbation frequency, symptom control, weight and tolerability)

Your healthcare provider may also update your plan if you have new exacerbations, changes in lung function, or new comorbidities.

15. Delivery & Availability (Online Pharmacy Considerations)

Availability of Daliresp can vary by supplier and tablet strength. When ordering online in Australia, consider the following:

• Stock availability: Some strengths may be available sooner than others.
• Packaging checks: Ensure the product is sealed and within the use-by date on arrival.
• Delivery timeframes: Shipping estimates depend on location and courier services.
• Cold chain: Daliresp typically does not require refrigeration, but follow the instructions on the label.

If you need urgent medication due to severe symptoms, contact the pharmacy promptly to confirm dispatch time and delivery options.

16. Daliresp FAQ (Frequently Asked Questions)

1) Is Daliresp a rescue medicine for sudden breathing difficulty?

No. Daliresp is intended as a maintenance treatment to help reduce COPD exacerbations in selected patients. It is not a substitute for rescue inhalers or emergency care.

2) How long does it take before Daliresp works?

Benefits are usually assessed over time. Some people notice changes over weeks, while exacerbation reduction may be evaluated over months. Follow-up with your clinician helps determine whether it’s working for you.

3) What should I do if I miss a dose?

Take the missed dose when you remember unless it is close to your next dose. Do not take extra doses to make up for a missed one. If unsure, ask your pharmacist for advice.

4) Can I take Daliresp with food?

Yes. Daliresp can typically be taken with or without food. If you experience nausea or stomach discomfort, taking it with food may help.

5) Does Daliresp cause weight loss?

Weight loss and decreased appetite are known possible side effects. Your clinician may monitor your weight, especially if you are already underweight. Contact your healthcare professional if you notice significant or rapid loss.

6) Is it safe to drink alcohol while taking Daliresp?

Alcohol isn’t universally prohibited, but it may worsen side effects like nausea, dizziness, or diarrhoea and may affect mood or sleep. Keep intake low and seek advice if you notice increased adverse effects.

7) What other medicines can interact with Daliresp?

Drug interactions can occur, especially with medicines that affect liver enzymes or may add to side effects. Tell your pharmacist about all medications, including inhalers, antibiotics, antidepressants, seizure medicines, herbal products, and supplements.

8) What mental health warning should I know about?

Some patients may experience mood changes. If you develop new or worsening depression, anxiety, or suicidal thoughts, seek urgent medical help immediately.

9) Can I take Daliresp if I have liver problems?

Liver disease can affect how roflumilast is processed. Your clinician will consider your liver function and medical history before prescribing. Don’t adjust treatment without medical guidance.

10) Are there alternatives if I can’t tolerate Daliresp?

Yes. COPD management can involve different inhaled therapies, non-drug strategies (such as pulmonary rehabilitation), and other medicines depending on your condition and risk profile. Discuss options with your healthcare provider.

17. When to Seek Urgent Medical Help

Seek urgent medical attention if you experience any signs of a serious allergic reaction (e.g., facial swelling, difficulty breathing), severe or persistent diarrhoea leading to dehydration, or significant mood changes—especially thoughts of self-harm.

If you’re concerned about side effects that aren’t listed here, contact your healthcare professional or pharmacist for advice.

Summary

Daliresp (roflumilast) is an oral medicine used as a maintenance add-on for selected adults with COPD who are at risk of exacerbations. It works by inhibiting PDE4 to reduce inflammatory pathways involved in COPD. The medicine is taken once daily, can generally be taken with or without food, and may require monitoring for side effects—particularly gastrointestinal symptoms, weight loss, and mood changes. For the best outcomes, take it consistently as directed, track your weight, report concerning symptoms promptly, and keep your overall COPD plan optimised.